Suzhou Zelgen Biopharmaceuticals Co., Ltd.

¥90.80As of Sun 8 Nov 2026, 12:00 UTC
SSE:688266Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR 2.95%
Div yield —
ROE 39.66%
Biotechnology
Beta (5Y) 0.03
PE TTM 41.71
TSR TTM (12.59%)
Mkt cap ¥24.04B
ROIC 13.47%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥97
6.99%
(80.16%)
Hold 10|7|9|6|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.29
1.25
1.30
1.31
4.84%
1.93%
6.99%
4.06%
Revenue¥B
1.296
1.340
1.389
1.401
4.57%
3.70%
7.42%
6.20%
Peers (US$3.603B)
Cap (US$)
PE
3.756B
35.19x
3.409B
26.88x
3.366B
38.24x
Capital
TTM
5Y
10Y
Leveragex
2.140
0.151
0.136
EBIT/Intx
0.465
0.273
0.261
Own earn%
(8.53)
(224.19)
(193.19)
Sh yield%
32.70
47.46
48.37
Owners
Insiders/Inst%
13.62
32.59
Short interest%
3.32
SBC / revenue%
2.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
4–10
$1 testx
—
Incr. ROIC%
12